Zevra Therapeutics, Inc. Current Liabilities
Zevra Therapeutics, Inc. (ZVRA) had Current Liabilities of $48.63 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $48.63M.
- 2026-03-31: Liabilities, Current $47.03M.
- 2025-12-31: Liabilities, Current $39.28M.
- 2025-09-30: Liabilities, Current $26.11M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $48.63M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $47.03M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $39.28M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $26.11M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $28.83M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $26.98M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $34.06M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $34.48M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $30.45M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $29.91M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $73.72M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $21.71M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $18.25M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $15.62M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $12.02M 10-K · filed 2024-04-01 | $11.73M 10-K · filed 2023-03-07 |
| 2022-09-30 | $8.43M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $7.16M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.94M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.23M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $3.70M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.96M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $4.24M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $7.54M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $70.80M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $72.55M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $75.56M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $5.43M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $10.41M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $14.97M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $15.17M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $12.00M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $18.32M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $17.60M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $13.81M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $11.51M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $6.65M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $6.59M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $4.81M 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $6.64M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $5.70M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $7.39M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $5.84M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $8.34M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $6.79M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $4.91M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $4.03M 10-Q · filed 2015-05-29 | |
| 2014-12-31 | $3.94M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |